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   ABSTRACT 
 
B cells play an important role both in the physiology and pathology of 
immune responses by production of antibodies, cytokines and by 
presentation of antigens. It has been shown that human CD25 
expressing B cells display a mature phenotype, perform better as 
antigen presenting cells but secrete less immunoglobulins. 
The aim of this thesis was to investigate human CD25 expressing B 
cells phenotypically, not only in healthy individuals but also in 
patients with rheumatoid arthritis (RA) and systemic lupus 
erythematosus (SLE). Further, we have also studied the phenotype and 
function of CD25 expressing B cells in mice.  
Our results from human studies show that CD25+ B cells display a 
highly mature and activated phenotype. These cells show high 
expression of IgA, IgG and CD80, and low expression of IgD and IgM 
both in healthy individuals and in RA patients when compared to 
CD25- B cells. CD25+ B cells from SLE patients did not show any 
difference in IgA and IgG expression but did expressed higher levels of 
the costimulatory molecule CD80 when compared to CD25- B cells. 
Furthermore, we have shown that 60% of CD27+ B cells in healthy 
controls, 51% in RA and 48% in SLE patients coexpressed CD25, 
suggesting that CD25+ B cells belong to the memory B cell population. 
Finally, CD25+ B cells were able to produce IL-10 in much higher levels 
than CD25- B cells. 
In mice, CD25 expressing B cells from secondary lymphoid organs 
showed a mature and activated phenotype, high expression of the 
costimulatory molecules CD80 and CD86, in addition to IgA, IgG, and 
the early activation marker CD69. Functionally these B cells were 
efficient alloantigen presenting cells, they spontaneously secreted 
high levels of immunoglobulins of the IgA, IgG and IgM classes, were 
able to become antigen specific antibody secreting cells and produced 
high levels of different cytokines including IL-4, IL-6, IL-10, and IFN-γ.  
In conclusion, we have shown that human CD25 expressing B cells 
display a highly mature and activated phenotype and belong to 
memory B cell subset. Also, in mice there was a clear difference both 
phenotypically and functionally between the CD25+ versus CD25- B 
cells. These data suggest that CD25 expressing B cells play a major 
role not just in the physiology of the immune system but also may 
participate in the pathogenesis of autoimmunity.  
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ABBREVIATIONS 
 
Anti-CCP  Anti-cyclic citrullinated peptide antibody 
APC   Antigen presenting cell 
APRIL   A proliferation-inducing ligand 
BAFF   B cell activation factor of the TNF family 
BCR   B cell receptor 
Breg    B regulatory cells 
CD   Cluster of differentiation 
CpG-ODN  CpG oligodeoxynucleotides 
DC   Dendritic cell 
EBV   Epstein-Barr Virus 
FDC   Follicular dendritic cell 
FO B cell  Follicular B cell 
GC   Germinal centre 
IFN-γ   Interferon gamma 
Ig   Immunoglobulin 
IL   Interleukin 
IL-2R   Interleukin-2 receptor 
LPS   Lipopolysaccharide 
LT   Lymphotoxin 
MHC-II  Major histocompatibility complex class II 
MLR   Mixed lymphocyte reaction 
MZ   Marginal zone 
Pam
3
Cys N-palmitoyl-S-[2,3-bis(palmitoyloxy)-(2RS)-propyl]-
[R]-cysteinyl-[S]-seryl-[S]-lysyl-[S]-lysyl-[S]-lysyl-[S]-
lysine × 3 hydrochloric acid 
PAX5   Paired box protein 5 
PBMC   Peripheral blood mononuclear cells 
RA   Rheumatoid arthritis 
RAG1   Recombination-activation gene 1 
RF   Rheumatoid factor 
RSV   Respiratory syncytial virus 
S. aureus  Staphylococcus aureus 
sCD25  Soluble CD25 
SCF   Stromal cell factor 
SLE   Systemic lupus erythematosus 
TCR   T cell receptor 
TLR   Toll like receptor 
TNF   Tumour necrosis factor
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INTRODUCTION 
 
The immune system is formed of two highly overlapping parts, the 
innate and adaptive immunity. The innate immunity is non-antigen 
specific and reacts early on against, for example, invading microbes. 
The adaptive immunity on the other hand refers to an antigen-specific 
immune response, is memory driven, and leads to affinity maturation 
of subsequent responses. The most important task of the immune 
system is to defend the organism against foreign invaders and to 
guarantee its survival. It is also important that the immune system 
distinguishes between self and non-self to avoid reactions against the 
host’s own tissues. In order to do this, the immune system has evolved 
different mechanisms resulting in tolerance. If tolerance is lost in the 
immune system this may lead to the development of autoimmunity or 
allergy.  
B cells play an important role in both the innate and the adaptive 
immune system by producing antibodies, cytokines and presenting 
antigens to the T cells [1, 2]. B cells can also play a pathogenic role in 
adaptive immune responses by producing autoantibodies, 
proinflammatory cytokines and participate in autoantigen 
presentation, which give them a role as one of the major players in the 
development of autoimmune diseases such as rheumatoid arthritis 
(RA) and systemic lupus erythematosus (SLE) [3-5]. Understanding the 
B cell subsets in order to investigate their role in health and disease is 
of great importance, especially for the development of B cell specific 
therapies. The aim of this thesis is to address a B cell subset of human 
and mice characterised by its expression of surface IL-2Rα (CD25) and 
to investigate its role in the immune system.  
The first two papers in this thesis deal with the phenotypical 
characteristics of CD25 expressing B cells in patients with RA, SLE and 
in healthy controls. Paper I shows that CD25 expressing B cells display 
a mature and activated phenotype both in RA and SLE patients, and  
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healthy controls. Comparing CD25+ B cells in RA and SLE patients to 
CD25+ B cells in controls we found that CD25+ B cells in patients were 
more mature and activated. Paper II shows that CD25 expressing B 
cells in both RA and SLE patients and in healthy controls belong to the 
memory B cell subset. 
The next two papers deal with CD25 expressing B cells in mice. Paper 
III describes the presence of CD25 expressing B cells in primary and 
secondary lymphoid organs and shows that CD25 expressing B cells in 
secondary lymphoid organs are highly mature and activated as 
compared to CD25 negative B cells. Finally, Paper IV describes 
functional properties of CD25 expressing B cells in healthy mice, 
showing that CD25+ B cells are efficient alloantigen presenting cells, 
they spontaneously secrete high levels of immunoglobulins, are able to 
become antibody producing cells upon antigenic challenge and 
produce high levels of various cytokines as compared to CD25- B cells.  
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B CELL DEVELOPMENT 
 
B cells develop from haematopoietic stem cells located in the liver of 
foetus and later in the bone marrow of adults. Several transcription 
factors including early B cell factor, PU.1, E2A and paired box protein 5 
(PAX5) are important for early development and commitment of stem 
cells to the B cell lineage [6]. Also, the stromal cells in bone marrow 
and their products like stromal cell factor (SCF) and chemokine 
CXCL12 are important for the B cell development. The cytokine IL-7 
has been shown to be necessary in the development of B cells in mice 
but not in humans [7]. 
A successful rearrangement of immunoglobulin (Ig) heavy (H) and Ig 
light (L) chain loci will ensure that the developing B cells express a 
membrane-bound antibody as an antigen receptor, called the B cell 
receptor (BCR). The immunoglobulin heavy chain locus rearrangement 
in pro-B cells leads to formation of a precursor BCR which express the 
transmembrane form of the µ IgH together with two proteins, λ5 and 
VpreB, forming surrogate light chain and two invariable accessory 
chains, Igα and Igβ [8, 9]. Expression of the pre-BCR on the cell surface 
will signal for starting of light chain rearrangement and once this is 
completed, the immature B cell will express a complete IgM molecule 
on its surface [10, 11]. Both in humans and mice, there are two light-
chain loci κ and λ, where κ tends to rearrange before the λ locus. 
Immature B cells go through a central tolerance checkpoint where 
autoreactive B cells will be killed or forced to rearrange their BCR (so 
called receptor editing), by reactivating their recombination-activating 
genes (RAG1) and (RAG2) and expressing a new Ig light chain and thus 
acquiring a new specificity [12, 13]. B cells that survive this selection 
are called mature B cells and will undergo further differentiation 
resulting in expression of IgD, in addition to IgM on their surface. 
After this step mature B cells will leave bone marrow. 
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Functional B cell receptors that have been formed, have high diversity 
that is generated in different ways. There are multiple copies of V 
(variable), D (diversity) and J (joining) gene segments of heavy chains 
and V and J gene segments of light chains that can be combined in 
multiple ways to give rise to B cell receptors with different specificity. 
Also, the addition and subtraction of nucleotides in the joints between 
gene segments during the process of immunoglobulin gene 
rearrangement results in further diversity. All rearrangement of Ig-
genes occurs randomly, generating an enormous variability of the BCR 
[14]. 
 
 
Figure 1: Stages of B cell development in bone marrow and peripheral 
lymphoid organs. 
 
There are other surface markers than IgM and IgD that will be 
expressed during the B cell development. B220 (CD45) and CD19 
which are involved in B cell receptor signalling are present on both 
human and mice cells while CD43, HSA and AA4.1 are expressed on 
very early B cells all the way to the immature B cells in mice [15]. For  
human the B cells makers CD10, CD24 and CD38 have been shown to 
be expressed on early developing B cells [16]. However, the function of 
these molecules for the B cell development is presently unknown.  
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CD25 and IL-7 receptor are expressed during the development of B 
cells in the bone marrow and may function as growth factor receptors 
in mice [7, 17]. We have recently shown that B cells expressing CD25 in 
bone marrow in mice are indeed of immature phenotype. CD25+ B cells 
coexpress high levels of AA4.1 when compared to CD25- B cells and 
have also lower expression of surface IgM and IgD ([18] paper III). The 
latter finding may suggest that CD25+ B cells, as they develop in the 
bone marrow will lose their expression of CD25 and leave this organ 
as CD25- B cells. Whether this also is true for human B cells is 
presently unknown. 
The development of B cells will continue in the secondary lymphoid 
organs. Mature B cells go through another tolerance checkpoint in the 
peripheral organs where B cells that still recognise self antigens in the 
absence of specific T cell help will become anergic [19]. A small 
population of mature B cells home to the spleen and remain there as 
non-circulating marginal zone B cells. However, most of the mature B 
cells start to circulate between follicles in the spleen, the lymph nodes, 
and bone marrow until they meet the BCR specific antigen. There after 
they will undergo further maturation and become memory B cells, 
plasma cells, or die. 
In the humoral immune response antibody production is of great 
importance. B cells have to become mature, have T cell help and meet 
their antigen in order to go trough somatic hypermutations and 
become antibody-producing cells. Mature B cells will then go through 
two genetic alterations in their immunoglobulin gene locus, a) class 
switch recombination (isotype switching) and b) somatic 
hypermutation (affinity maturation) [20-23] in order to become 
antibody producing cells. Somatic hypermutation introduce point 
mutations in the V region of heavy and light chain genes resulting in 
mutated BCR on mature B cells. This does not affect the C (constant) 
region gene of the BCR. B cells carrying immunoglobulins generated by  
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somatic hypermutation, will be able to bind the antigen with higher 
affinity than the original BCR and will be selected for to mature and 
eventually become antibody-secreting cells. This will give rise to high 
affinity maturation of the antibody population. Marginal zone (MZ) B 
cells and B-1 cells can become antibody producing cells without T cell 
help [24].  
 
 
IMMUNOGLOBULINS 
 
B cells are well known for their ability to secrete antibodies. The 
secreted antibodies display the same specificity as the BCR on the B 
cells. Antibodies are Y shaped and consist of two heavy chains and 
two light chains. The four chains forming an antibody are assembled 
in two Fab arms and the Fc region [25]. The chains are identical giving 
the antibody two alike antigen-binding sites.  There are two types of 
light chain, lambda (λ) and kappa (κ), a B Cell will express only Igλ or 
Igκ, but not both. However, there is no known functional difference 
between them. The isotype of the antibodies is determined by the 
heavy chain portion. There are five major classes of heavy chain that 
give rise to five different immunoglobulin isotypes, immunoglobulin M 
(IgM), IgD, IgA, IgG and IgE. IgA antibodies can further be divided in to 
two subsets: IgA1 and IgA2. IgG may further be divided into four 
subclasses in humans (IgG1, IgG2, IgG3 and IgG4) and in mice (IgG1, 
IgG2a, IgG2b and IgG3). IgA, IgG and IgE are monomers when secreted, 
while IgA is a dimer in mucosal environment and IgM forms a 
pentamer [26]. Antibodies have multiple immunological functions 
including opsonization of microbes, immune complex formation, 
neutralisation of toxins and complement activation.
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B CELLS IN THE INNATE IMMUNE SYSTEM 
 
B cells are specialised to produce high affinity antibodies and thereby 
considered to be part of adaptive immune system. However, there are 
B cell subsets, such as B-1 cells and marginal zone (MZ) B cells that 
also participate in innate immune responses by producing natural low 
affinity antibodies (antibodies of IgM isotype that are present in the 
body without any apparent evidence of infection) and may play a role 
in the early defence against foreign antigens such as encapsulated 
bacteria. 
 
The B-1 subset of B cells 
The B-1 subset of B cells produce low affinity antibodies, displays a 
different phenotype and location in the body as compared to 
conventional B cell (B-2) [27, 28]. In mice the B-1 cells are 
phenotypically characterised as IgMhighIgDlowCD23-B220low with Mac-1 
expression on peritoneal but not on splenic B-1 cells [29]. These B cells 
can be further divided into B-1a, expressing CD5 and B-1b, which do 
not express CD5. It is unknown if the B-1a and B-1b B cells are derived 
from the same or different progenitor cells [30]. The existence of this 
B cell subset in humans is still a matter of debate. 
It has been shown that surface CD19 plays an important role in B-1 
cell development. Mice deficient in CD19 have impaired B-1a cell 
development and lower production of natural antibodies. 
Overexpression of CD19 results in an increased B-1a cell development 
but impaired B-1b development as well as an impaired adaptive 
immune responses to antigens [31-34]. Transgenic and gene targeted 
mice studies have shown strong evidence that BCR signalling is critical 
for B-1 cell development. Mutations that enhance BCR signal (deletion 
of SHP-1, CD22, CD72, Lyn) result in an expansion of the B-1 
compartment while mutations that disrupt the BCR signal (deletion of  
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CD19, CD21/35, PI3-kinas, vav-1, BLNK/SLP-65, btk) result in a 
decreased B-1 compartment, as reviewed in [27, 28]. B-1 cells are 
responsible for the early humoral responses against different 
pathogens. They are primary antibody producers in response to T cell 
independent type 2 antigens, recognise common bacterial antigens like 
certain bacterial cell wall components and provide the first line of 
defence against these pathogens.  
Antibodies produced by B-1 cells have low affinity and are usually 
polyreactive. B-1 cells produce mostly antibodies of IgM isotype. In 
fact, one study has shown that B-1a cells produce natural antibodies 
against capsular polysaccharides while B-1b cells produce antibodies 
induced by antigen specific response against the same antigen [34]. It 
has also been shown that peritoneal B-1 cells are main producers of T 
cell independent IgA in the gut [35]. We have shown that CD5 positive 
B cells are present in Peyer´s patches of healthy mice ([18] paper III). It 
may be that these cells mature in the peritoneal cavity or spleen and 
home to the gut keeping their expression of CD5. 
 
Marginal zone B cells 
Blood enters spleen through a structure called the marginal sinus, and 
flows through the marginal zone and venous sinuses before returning 
to the circulation [36]. Cells located in the marginal zone are 
constantly in contact with large amounts of blood and consequently 
with any antigen that may have entered the circulation. There are 
different cell types found in the marginal zone of a spleen. For 
example, two populations of macrophages (marginal metallophilic 
macrophages and marginal zone macrophages), fibroblasts, dendritic 
cells (DC) and B cells [37].  Blood born CD11clow immature DC has been 
shown to efficiently capture bacteria and transport them to the MZ of 
the spleen, providing bacterial antigens to MZ B cells. These DCs 
produce B lymphocyte stimulator (BAFF) and a proliferation-inducing 
ligand (APRIL) providing critical survival signals to antigen specific MZ  
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B cells promoting them to differentiate into IgM producing 
plasmablasts [38]. 
The location of MZ B cells permits them to respond to blood born 
pathogens and initiate a T cell independent antibody response to 
encapsulated bacteria [37]. MZ B cells do not belong to the re-
circulating pool of lymphocytes in spleen and represent only about 5% 
of splenic B cells. These B cells can be characterised by their surface 
expression of IgMhighIgDlowCD23lowCD21highCD38highCD9high [39, 40]. CD21, a 
complement receptor, is highly expressed on MZ B cells. CD21 is part 
of the BCR and together with CD19 and CD81, it lowers the threshold 
for BCR activation of B cells. CD21 binds C3d coated antigen, this 
complex then leads to cross-linking of CD19 and CD81 and B cell 
activation [41]. MZ B cells also express higher levels of LFA-1, α4β7 
integrin, and B7 proteins (CD80 and CD86) [24, 42]. LFA-1 and α4β7 
integrin are homing receptors guiding the B cells to the site where they 
are needed. It has been shown that MZ B cells, compared to follicular B 
cells, have the ability to efficiently upregulate costimulatory molecules 
in response to early activation in vitro, proliferate much faster in 
response to low doses of polyclonal mitogens and differentiate into 
plasma cells within hours of activation [24]. 
We have investigated if MZ B cells in healthy mice express CD25. 
However, on comparison of CD25+ versus CD25- B cells in spleen, the 
expression of IgD was high on both subpopulations making it difficult 
to classify them into either MZ or follicular B cells ([18] paper III).  
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B CELLS IN THE ADAPTIVE IMMUNE SYSTEM 
 
B-2 cells 
B-2 cells or follicular B cells (FO B cells) are important for long-term T 
cell dependent antigen responses. The B-2 cells may switch isotype 
and differentiate into high affinity memory B cells and to long-live 
plasma cells. The high affinity memory generation is associated with 
the capacity of B cells to undergo somatic hypermutation. 
 
Regulatory B cells 
Recent experimental studies have indicated the existence of a distinct 
B cell subset that suppresses the development and enhances the 
recovery from an adaptively mediated immune inflammation by 
production of IL-10. These B cells have now been termed regulatory B 
cells (Breg). IL-10 has anti-inflammatory activities that includes down 
regulation of costimulatory molecules on the antigen presenting cells 
(APCs), which are directly involved in the differentiation of Th1 
response and in the inhibition of antigen-specific T cell proliferation 
[43, 44].  IL-10 producing B cells have been identified in the diseases 
models such as experimental autoimmune encephalomyelitis (EAE) 
[45],  experimental RA [46], experimental SLE [47, 48] and in mice 
infected with Schistosoma mansoni  [49]. In vitro studies have shown 
that even human B cells have the ability to produce IL-10 [50]. We have 
shown that human CD25+ B cells produce IL-10 when stimulated with 
CpG-ODN ([51] paper II). In addition, our results from mice studies 
show that CD25+ B cells secrete IL-10 following CpG-ODN, LPS or 
Pam
3
Cys stimulation ([52] paper IV), suggesting that CD25+ B cells may 
perhaps be a part of both regulatory and innate B cell responses in 
human and mice.  
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Memory B cells 
During the last part of T cell dependent immune responses to an 
antigen the immunological memory is formed. Immunological memory 
in the humoral immune system is based on two different pathways of 
cellular differentiation. One results in the generation of antigen 
independent, long-lived memory cells that respond to the new 
antigenic challenge by rapid differentiation into plasma cells. The 
other pathway results in generation of a population of long-lived 
antibody producing plasma cells that are independent of sustained 
antigenic challenge.  
Memory B cells have been characterised by expression of CD27 in 
humans [53, 54].  CD27, a type 1 glycoprotein, is a member of the 
tumour necrosis factor (TNF) receptor family with unique cysteine rich 
motifs and is expressed on B and T cells. In adults, 32% of circulating B 
cells express CD27 as compared to 4% of B cells in cord blood. 
Morphologically, CD27 positive B cells are larger with abundant 
cytoplasm when compared to CD27 negative B cells. Functional 
difference has also been identified between CD27 positive and 
negative B cells. When stimulated with Staphylococcus aureus Cowan 
strain (SAC) plus IL-2 in vitro, CD27 positive B cells are quickly 
activated and produce high levels of IgA, IgM and IgG [55]. We have 
shown that human CD27 expressing B cells coexpress CD25, figure 2. 
CD25+CD27+ memory B cells are mature and immunoglobulin class 
switched ([51] paper II). The expression of CD25 on memory B cells can 
be an indication that these cells respond to IL-2. Alternatively, CD25 
may be a specific marker for a memory B cell subpopulation. It has 
been shown earlier that neutralization of CD25 prior to mixed 
lymphocyte reaction (MLR) will abolish the antigen presenting ability 
of CD25+ B cells [56]. This is strong evidence that CD25 has other roles 
on the B cell surface than only to be a part of the high affinity IL-2 
receptor.  
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Figure 2: The expression of CD25 on different B cell subsets.  
 
Memory B cells produce high affinity antibodies, this is primary 
achieved by somatic mutation of Ig genes during B cell development. It 
has been demonstrated that the majority of IgM+IgD+CD27+ peripheral 
blood B cells carry mutated V-region genes compared to IgM+IgD+CD27- 
B cells [54]. B cells need to be activated by antigens via their B cell 
receptor, cytokines and direct cell-to-cell contact in germinal centre 
(GC) or by Toll-like receptors (TLRs) to develop into memory B cells or 
plasma cells. GC formation and CD40-CD40L interaction is necessary 
for somatic hypermutations and generation of long-lived memory B 
cells [57, 58]. 
In contrast to human memory B cells there are no good phenotypic 
markers for memory B cells in mice. So far analyses of somatic 
hypermutations have been the only way to identify memory B cells in 
mice. However, using a transgenic mice model Anderson et al have 
recently shown that CD80+CD35low B cell population in mice is 
somatically mutated belonging to the memory B cell population [59]. 
We have shown that CD25+ B cells in mice have properties of memory 
B cells. CD25+ B cells secrete and express higher levels of IgA and IgG  
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immunoglobulins. Furthermore, in response to immunisation CD25+ B 
cells produce higher levels of antigen specific antibodies of IgG and 
IgM subclasses ([52] paper IV). We suggest that CD25 can be used as a 
memory marker for mice B cells, however it is important to point out 
that genetic studies will be needed to confirm that.   
 
Plasma cells 
The final differentiation state for a B cell is to become an antibody 
secreting plasma cell. Marginal zone B cells responding to T cell 
independent antigens and circulating mature follicular B cells 
responding to T cell dependent antigens are the first B cells to 
differentiate into plasma cells. Plasma cells are formed either by 
follicular or marginal zone B cells in early extrafollicular response. 
These cells do not go through somatic mutation of their 
immunoglobulin genes and are considered to be short-lived, IgM 
producing plasma cells. In contrast, plasma cells originating from 
germinal centre reactions go through somatic mutations and may 
become long-lived plasma cells that home for example to bone 
marrow. 
Antibodies secreted by plasma cells have high affinity for a specific 
antigen and are an important part of the humoral adaptive immunity. 
However, the half-life of the antibodies in blood is short and is 
estimated to only few weeks. Since antigen specific antibodies can be 
detected for decades after immunization this indicates a continuous 
de novo production suggesting regeneration or a steady state of 
plasma cells. Exactly how long a plasma cells can live is unknown, but 
it has been suggested that they can survive between a few days and up 
to years [60]. Many studies have been performed in order to explain 
the stable long time concentration of specific antibodies found within 
the circulation. One theory is that there is a constant generation of 
new short-lived plasma cells from activated memory B cells. An 
existing mechanism for generating short-lived plasma cells from  
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memory B cells may be the presence of low quantities of an antigen 
over a long period of time [61]. Also, memory B cells can proliferate 
and differentiate into plasma cells in response to polyclonal stimuli 
via their Toll-like receptors and cytokine receptors [62]. Long-lived 
plasma cells that have homed to the bone marrow and constantly 
secret antibodies are also part of this immunological memory. 
During differentiation to plasma cells, B cells lose the expression of 
surface molecules such as surface immunoglobulins, major 
histocompatibility complex class II (MHC-II), CD19 and CD20. Another 
surface marker CD38 is kept on human plasma cells but is not 
detected on mouse plasma cells. The only protein that is increased on 
plasma cells in man and mouse is Syndecan-I (CD138) [63, 64]. 
Developing plasma cells have to exit the germinal centres and migrate 
to the bone marrow, to the mucosa or to the sites of inflammation 
[65]. As plasma cells are developing, the chemokine receptor 5 
(CXCR5) and CC-chemokine receptor 7 (CCR7) expression is down 
regulated. These chemokines control germinal centre trafficking and 
down regulation of these molecules allows post-germinal centre cells 
to exit from the follicles. The expression of CXCR4 is important for 
plasma cells to enable homing to the splenic red pulp, lymph node 
medulla and to the bone marrow [65, 66]. Human and mouse plasma 
cells that home to bone marrow express CXCR3, a chemokine receptor 
that also is upregulated on plasmablasts upon stimulation with IFN-γ 
which is mainly produced by inflammatory cells, indicating that IFN-γ 
might be important for attraction of plasmablasts to the inflamed 
tissue [67]. 
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B CELLS IN THE AUTOIMMUNITY 
 
When the self-tolerance is broken and cells of the immune system 
recognise self proteins as foreign, the immune system may start an 
attack that will result in inflammation and destruction of the affected 
tissue giving rise to an autoimmune disease. B cells mediating 
autoimmune diseases can be specific for one organ like in diabetes 
mellitus [68] or may involve many organs as in SLE [69].  
One of the systemic autoimmune diseases is RA. RA is characterised 
by chronic inflammation of the synovial membrane, resulting in 
synoviocyte proliferation, cartilage injury and bone erosion which can 
further result in deformations of joints [70]. The exact mechanisms of 
RA pathogenesis remain unclear, but involvement of cells like T cells, 
B cells, macrophages, neutrophils and synovial fibroblasts has been 
shown to be of importance [4, 71, 72].  
SLE is also a systemic autoimmune disease affecting joints, skin, 
kidneys, lungs, blood cells, blood vessels and the central nervous 
system. B cells, T cells and monocytes are involved in the pathogenesis 
of the SLE but the exact mechanism behind the development of the 
disease is not clarified. Genetic factors, sex hormones, defective 
immune regulation such as clearance of apoptotic cells and immune 
complexes, loss of immune tolerance, defective B cells suppression 
and environmental factors has been considered as some of the factors 
that are required to trigger the disease [73]. 
B cells have been shown to be a part of RA and SLE pathogenesis [4, 
69]. Exactly how they participate is presently unclear, however some 
suggestions have been made regarding B cells ability to produce 
autoantibodies, present antigen to T cells and secret proinflammatory 
cytokines [1, 74]. However, B cells targeted therapy can successfully 
ameliorate these conditions [75-77].  
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During the B cell development in the bone marrow randomly selected 
heavy and light chains are combined to form functional BCR. The 
specificity of combined chains is impossible to predict and it has been 
suggested that almost 50% of BCRs may carry high degree of 
autoreactivity [78]. To have autoreactive cells in the body is not 
desirable so self-tolerance control mechanism in bone marrow and 
later in the periphery exists. Autoreactive B cells will be deleted by 
receptor editing, clonal deletion, or inactivation (anergy). RA and SLE 
patients display a defective B cell tolerance in more than one of these 
mechanisms [79]. The levels of BAFF in sera and synovial tissue of RA 
patients are high and may cause the inappropriate survival of 
autoreactive B cell clones [80]. High levels of BAFF have also been 
shown to drive autoantibody production in RA and SLE [81]. The 
survival and proliferation of autoreactive B cells will result in an 
increased production of autoantibodies. 
 
Autoantibodies 
Rheumatoid factor (RF) is one of the autoantibodies that binds the Fc 
portion of IgG. RFs can be of any isotype but IgM is the most common 
one. They are found in about 70-80% of RA patients but may be 
detected in other autoimmune diseases, systemic infections as well as 
up to 4% of healthy individuals [82]. Other autoantibodies that may 
play a role in the pathogenesis of RA are antibodies to cyclic 
citrullinated peptides (anti-CCP) [83], anti-keratin, anti-filaggrin and 
many more, reviewed in [84]. In SLE, the most common autoantibody is 
antinuclear antibodies with a specificity to anti-double stranded DNA 
[85]. Autoantibodies form large immune complexes that activate B 
cells and follicular dendritic cells via Fc receptors and complement 
receptor 1, CR1 (CD21) and CR2 (CD35) [86, 87]. TLRs, together with a 
second signal delivered by BCR ligation have been shown to be 
important in the induction of RF producing B cells. It has been shown  
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that memory B cells express TLRs and can be activated by ligation of 
the TLRs alone [82]. B cells in most autoimmune diseases are mature 
and differentiated, it is thus possible that B cells producing 
autoantibodies will be activated through TLRs without the need for 
BCR ligation (T cell independent) and produce low affinity 
autoantibodies. The memory B cells (CD19+CD27+CD25+) we have 
investigated from RA and SLE patients display a more mature 
phenotype ([51] paper II). Even if we lack the functional data regarding 
these cells it may be that CD25 expressing memory B cells are part of 
the memory B cell pool that may have the ability to become activated 
without T cell help and secrete autoantibodies and/or differentiate to 
autoantibody secreting plasma cells.   
 
Cytokines 
In the past B cells have not been considered to be a major source of 
cytokines. However, many studies have shown that B cell can produce 
a wide spectrum of cytokines. Cytokines are polypeptides produced by 
different cells in response to foreign antigens, mediating and 
regulating the immune system and inflammatory reactions. Peripheral 
stimulated B cells from healthy individuals secrete IL-6, TNF and 
lymphotoxin (LT) upon BCR and CD40 engagement [50]. These 
cytokines act not only as differentiation and autocrine factors but may 
also amplify the immune responses. IL-10 produced by B cells 
suppresses harmful immune responses and regulates the balance of 
Th1/Th2 [46]. IL-10 can also activate follicular dendritic cells (FDCs) 
and stimulate B cells. The effect of IL-10 on mice B cells is still 
discussed. It has been shown that IL-10 inhibits the antibody 
production by B cells [88] but also that IL-10 increases the expression 
of IgG3 in LPS activated B cells [89]. IL-10 is known to have an 
inhibitory effect on other cells of immune system like the T cells. 
Reports on regulatory B cells producing IL-10 has shown that these 
cells play a key role in controlling autoimmunity [45, 90]. We have  
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shown that both human and mouse CD25 expressing B cells have the  
ability to produce IL-10 after stimulation by TLR agonists ([51, 52] 
papers II and III). This can give them a role in the regulation of 
autoimmune diseases. Cytokines like IL-6, produced by activated 
human B cells, functions in an autocrine fashion by inducing 
differentiation into antibody producing B cells on those B cells that do 
express IL-6 receptor [91, 92]. The bacterial stimuli CpG-ODN induced 
production of IL-6 from mice B cells [93]. Also, INF-γ can act directly on 
the B cells to produce antibodies predominantly of IgM isotype, with 
IgG3 and IgG2a being the majority of non-IgM antibodies secreted [94].  
Figure 3: The function of a B cell in immune system and disease. 
 
Chemokines 
Binding of LT-β to its receptor induces expression of chemokines 
(CCL19, CCL21, CXCL12 and CXCL13) and adhesion molecules that  
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regulate lymphocyte homing and compartmentalization in lymphoid 
tissues. Chemokines are small proteins that stimulate the migration of  
phagocytes and lymphocytes. They have a central role in early 
inflammatory response directing cells to the inflamed tissue. It has 
been shown that B cells from RA and SLE patients have a distinct 
expression pattern of the chemokine receptors CXCR3, CXCR4 and 
CXCR5 when compared to healthy controls [95]. This is an indication 
that there are changes in lymphocyte trafficking in these patients. 
CXCL13, involved in the recruitment of B cells and LT-β have been 
shown to contribute to the formation of ectopic lymphoid tissue in RA 
patients [96, 97]. 
 
Antigen presentation 
Another important function of B cells is the ability to present antigen. 
B cell takes up, internalize and process antigen into small peptides, 
which are then presented on MHC-II molecules. One of them, HLA-DR4, 
have shown a strong association with occurrence of RA [98].  RF 
positive B cells have also been shown to be antigen presenting cells 
[99]. Both human and mouse CD25 expressing B cells have the ability 
to present alloantigen in contrast to CD25- B cells [56] ([52] paper IV). 
We have not examined the ability of these cells to present autoantigen 
in RA or in SLE as it has been shown that neutralisation of CD25 on 
the surface of human B cells before performing MLR abolished the 
ability of these cells to present alloantigen. We hypothesise that CD25+ 
B cells also may present autoantigen in RA and SLE. 
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IL-2 RECEPTOR 
 
Studies in the eighties of human spleen, tonsils, and blood B cells 
reported that a monoclonal antibody reacting with IL-2 receptor 
molecule expressed by activated T cells (anti-Tac) also bound S. aureus 
activated B cells. These B cells proliferated in response to IL-2 and IL-2 
induced proliferation was inhibited by the addition of anti-Tac in the 
cell culture [100, 101]. Lowenthal et al, showed that mitogen activated 
mouse B and T cells expressed both high and low affinity IL-2 
receptors [102]. 
The interleukin-2 receptor (IL-2R) is expressed on B cells, T cells, NK 
cells and eosinophils [103-105] and also on certain tumour cells [106]. 
Interleukin-2 (IL-2), the ligand for IL-2R, is a cytokine with distinct 
activities on the immune system stimulating proliferation of B and T 
lymphocytes, and NK cells.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4: High affinity IL-2 receptor. 
 
The receptor consists of three distinct sub-chains, alpha (IL-2Rα, CD25, 
Tac antigen), beta (IL-2Rβ, CD122) and gamma (IL-2Rγ, CD132). CD25  
α-chain (CD25) 
γ-chain (CD132) 
β-chain (CD122) 
IL-2 
IL-2 Receptor 
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alone binds IL-2 with low affinity but is not capable of signal 
transmission. CD122 and CD132 together form an intermediate 
affinity IL-2 receptor complex. The high affinity IL-2R is formed when 
all three subunits CD25, CD122 and CD132 come together [107]. 
CD122 and CD132 are also part of other cytokine receptors. CD122 is 
a part of the receptor for IL-15 and CD132, (also known as common 
gamma chain), is a part of IL-4, IL-7, IL-9, IL-15 and IL-21 receptors 
[108]. When IL-2 is present in low concentration it will bind to high 
affinity IL-2R, whereas IL-2 at high concentrations binds intermediate 
and high affinity IL-2Rs on murine B cells [109].  
 
 
CD25 FUNCTION 
 
IL-2Rα (CD25) is a 55 kDa polypeptide with an extracellular domain 
(219 amino acids), transmembrane domain (19 amino acids) and 
cytoplasmic domain (13 amino acids). The gene encoding CD25 is 
located on chromosome 10 in humans and chromosome 2 in mice and 
is highly conserved between the species [110]. In the thymus, 
thymocytes that go through a stage that marks the first step in T cell 
receptor (TCR) rearrangement and irreversible commitment to the T 
cell lineage, express CD25 [111]. CD25 is also expressed on mouse 
bone marrow developing B cells (pre-B cells) [112]. These B cells do not 
proliferate in response to IL-2 [17]. So far the function of CD25 on 
these early B cells is unknown. Neither is it known if human B cells 
express CD25 during the development in bone marrow and if they do 
during which part of the differentiation. One study using different 
human cells lines mirroring B cell maturation stages have shown that 
CD25 was expressed in the final stage of B cell lineage maturation, 
suggesting that the IL-2 and IL-2R was not required early during 
human B cell development [113]. However, it is important to keep in  
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mind that B cell lines, even if very similar to the normal B cells have 
important differences.  
Mice having disruption in the CD25 coding gene have similar 
phenotype as mice that lack the IL-2 gene [114, 115]. This suggest, that 
even if CD25 expression is not required for binding of IL-2 and further 
mediating of intracellular signalling, it will still be needed as a part of 
high affinity IL-2 receptor to mediate biological effect of IL-2 for the 
cell. In fact lymphocyte development in bone marrow is normal in IL-
2/CD25 deficient animals. However, young mice develop polyclonal 
expansion of the peripheral lymphoid compartment with increased 
numbers of all major cells types suggesting a global defect in 
lymphoid homeostasis. B cell activity in these animals is increased, 
detected by higher levels of immunoglobulins in the serum [114]. 
Several mouse studies have shown that IL-2/CD25 deficient mice 
develop different kinds of autoreactivity, they produce autoantibodies 
to red blood cells, antibodies specific for colonic tissue, many develop 
inflammatory bowel disease, and antibodies to DNA [107, 114]. In a 
mouse model of collagen type II induce arthritis when CD25+ cells 
were depleted, a more sever disease development was observed. 
However, there was no difference in the antibody titers against 
collagen in the absence of CD25 expression [116], suggesting a role for 
CD25+ T cells but a normal function of CD25+ B cells.  
CD25 deficiency in humans is more severe than in mice. Patients 
suffer from recurrent infections and lymphocyte infiltration in 
multiple tissues. It has been shown that humans deficient in CD25 
have a decreased apoptosis of developing T cells in thymus which 
affects the negative selection and results in release of autoreactive T 
cells causing inflammation in different tissues [117]. Although the 
effect of CD25 seems to be important for T cells, the somehow normal 
levels of immunoglobulins in serum indicates that CD25 expression in  
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B cells is not needed for class switch or secretion of immunoglobulins 
by B cells.   
IL-2 has been identified as a T cell growth factor promoting T cell 
growth in vitro. Signals provided by the TCR upregulate CD25 
expression, resulting in high affinity IL-2R expression, increased 
secretion of IL-2, and also the expression of Jak3, a critical signal 
inducing proliferation of T cells. In addition, CD25 can also be 
upregulated by TCR independent signalling through IL-1 and TNF 
[107]. Once the T cells express the high affinity IL-2R they will respond 
to IL-2 and start to proliferate. Importantly, IL-2 together with T cell 
help also promotes proliferation and differentiation of B cells, 
including secretion of IgM in primary B cell cultures [103]. Expression 
of CD25 on mature B cells have been considered as a marker for 
activated B cells [103]. However, most of the studies showing 
expression of CD25 on mature B cells are performed following B cell 
stimulation in vitro. The question if this is true in vivo is not resolved. 
In fact, about 30% of circulating B cells in healthy individuals express 
CD25 [56]. Whether, CD25 expression on B cells changes during an 
infection is still unknown in humans. It has been shown that 
neutralisation of CD25 on human B cells prior to performing MLR will 
abolish the CD4+ T cell proliferation suggesting the role for CD25 in 
alloantigen presentation [56]. This can be an indication that CD25 may 
have other function than only being a part of the high affinity IL-2R. In 
healthy mice 2% of splenic B cells express CD25 ([18] paper III). 
Interestingly in vitro exposure of splenic B cells to medium alone 
increases the CD25 expression to around 25%. Certain stimuli, for 
example LPS, CpG-ODN, and Pam
3
Cys, increase expression of B cell 
CD25 even more (our unpublished data). In contrast, in vivo 
experiments using S. aureus infected mice did not show any major 
upregulation of CD25 on B cells. B cells need CD25 expression for their 
differentiation but this may be strictly regulated during an infection  
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and the reason why B cell CD25 expression still is limited ([52] paper 
IV).  
 
Soluble CD25 
CD25 is present not only as surface molecule but also in a soluble 
form. Serum levels of soluble CD25 (sCD25) has been shown to be 
higher in individuals with RA and SLE compared to normal controls. In 
SLE, the presence of sCD25 in the serum increases with disease 
activation and drops when the patient recovers [118]. In vitro, the 
release of sCD25 is higher from peripheral blood mononuclear cells 
(PBMCs) in RA patients but less from cells of SLE patients when 
compared to controls. However, the serum levels were high in both RA 
and SLE patient when compared to controls. In RA patients it has been 
suggested that high serum levels of sCD25 will be a result of an 
increase in the spontaneous release of this protein from the activated 
cells, while in SLE patients this can depend on reduced clearance of the 
complex from the blood [119]. Even if these studies do not show any 
data regarding B cells alone, the involvement of these cells cannot be 
ruled out. However, the high concentration of sCD25 in biological 
fluids has so far been consider as an indication of T cell activation. 
There are no studies dissecting exactly which cells that are responsible 
for the release of sCD25. It can be speculated that in some 
autoimmune diseases, B cells can be the main source of sCD25 as they 
become activated in the presence of autoantigen and differentiate to 
plasma cells losing many of their surface molecules. Although, sCD25 
binds IL-2 with low affinity it still may act as an IL-2 antagonist in vivo 
by binding and neutralising its biological activity. IL-2/sCD25 complex 
may also form a deposit of IL-2 as the complex clearance from the 
circulation is much lower in SLE patients [120]. However, the role of 
sCD25 in the pathogenesis of the diseases such as RA and SLE has not 
been addressed. In addition, the serum levels of sCD25 is not just  
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increased in RA and SLE patients. Indeed, studies have shown that 
sCD25 is also higher during respiratory syncytial virus (RSV) infection 
[121] and in different forms of cancer [122] . 
 
 
HUMAN CD25+ B CELLS 
 
Phenotype of CD25+ B cells 
There are conflicting data regarding the expression of IL-2R subunits 
on human peripheral blood mononuclear cells in healthy individuals 
[56, 123]. In the peripheral blood from healthy individuals 
approximately 30% of the B cells express CD25 [56]. CD25 expressing B 
cells display a mature and class switched phenotype, having high 
expression of membrane bound IgA and IgG, and low expression of 
IgD and IgM when compared to CD25- B cells. The expression of MHC-II 
does not differ between CD25+ and CD25- B cells. However, CD25+ B 
cell have higher expression of costimulatory molecule CD80 and CD86 
([124] paper I). Approximately 60% of the memory B cell population 
identified by the expression of CD27 also coexpresses CD25, 
suggesting that CD25 expressing B cells are a part of memory B cell 
subpopulation ([51] paper II). The expression of costimulatory 
molecules are higher on the surface of these memory cells indicating 
that they have the ability to present antigens to T cells. Also, the 
expression of CD138, surface marker for plasma cells, was decreased  
strengthen the theory of these cells being in a mature/memory stage 
but not yet differentiated into plasmablasts. It seems like the 
plasmablasts downregulate the expression of CD25. In fact, B cells that 
lack CD25 expression have high surface CD138. The phenotype of 
CD25+CD27+ memory B cells suggests that these are highly activated 
and class switched memory B cells ([51] paper II).  
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Function of CD25+ B cells 
If human B cells are activated with anti-µ Ab and separated into CD25+ 
and CD25- populations, the CD25+ B cells responded to IL-2 but not to 
B cell growth factor (BCGF). In contrast, CD25- B cells responded to 
BCGF but not to IL-2 [125]. This suggest a fully functional high affinity 
IL-2 receptor on CD25+ B cells. IL-4 and PHA can also induce 
expression of CD25 on human tonsil B cells, while after stimulation 
with IL-2, IFN-γ and PWM, B cells do not express CD25. The ability of IL-
4 to induce CD25 on B cells was abolished by addition of IFN-γ to the 
culture [126]. The expression of CD25 on B cells was shown to be 
upregulated by stimulation of B cells with CpG-ODN, LPS and Pam
3
Cys, 
while GpC-ODN, EBV and polyIC did not upregulate the expression 
[56]. This shows a high degree of selectivity for expression of CD25 on 
B cells and suggests that these cells will be able to differentiate 
without T cell help. It was also shown that the expression of CD25 is 
NF-κB dependent [56].    
Functional differences between CD25+ and CD25- B cells have been 
demonstrated in healthy individuals. We have recently shown that RA  
 
 
 
 
 
 
 
 
 
 
Figure 5: CD25 expression on peripheral B cells of healthy individuals and 
patients with RA and SLE.  
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and SLE patients have CD25+ B cells in their circulation and 
consequently these B cells may be involved in the pathogenesis of 
these diseases, figure 5 ([51, 124] papers II and I). 
Unstimulated human CD25+ B cells secrete low levels of 
immunoglobulins of IgM, IgG and IgA subtypes when compared to 
CD25- B cells. However, they have high expression of membrane bound 
immunoglobulins of IgA and IgG classes ([56, 124] paper I) . As CD25+ 
B cells are a part of the memory B cell compartment not only in 
healthy controls but also in patients with RA and SLE, figure 6, ([51] 
paper II), it is expected that they will secrete less immunoglobulins 
until they receive an appropriate signal and differentiate to 
plasmablasts or plasma cells. Memory B cells have a lower threshold to 
become activated and differentiate into antibody secreting cells.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6: The CD25 expression on memory and naïve B cells of healthy 
controls and patients with RA and SLE. 
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resulting in the generation of autoreactive memory B cells. In addition, 
the autoantigen is constantly present activating mature and memory B 
cells. Comparing CD25+ B cells from RA and SLE patients to healthy 
subjects, we detected that the surface immunoglobulin expression of 
IgA and IgM in RA, and IgD and IgM in SLE patients were lower 
compared to healthy controls ([124] paper I). It is possible that CD25+ 
B cells in patients with autoimmune diseases display a faster turn-over 
of their surface molecules, leading to increased differentiation.  
When analysing the expression of the other two IL-2R subunits, CD122 
and CD132, we detected an increase expression of these two subchains 
on CD25 expressing B cells from RA and SLE as compared to healthy 
controls ([124] paper I). CD122 and CD132 are, in addition to the high 
affinity IL-2 receptor, also part of other cytokine receptors IL-4, IL-7, 
IL-9, IL-15 and IL-21. Cytokines affect B cells in different ways 
including differentiation to memory B cells or plasma cells and may 
thereby play a role in the disease. Memory B cells can be long lived, 
and together with the ability of a high turn-over rate and activation 
without T cell help they might be a major player in autoimmune 
disease if reacting to self antigens.  
When stimulated with CpG-ODN, CD25+ B cells secreted higher levels 
of IL-10 in contrast to CD25- B cells which secreted higher levels of IL-2 
([51] paper II). Why we detect lower secretion of IL-2 from CD25+ B 
cells may be an effect of autocrine consumption, as CD25 expressing B 
cells do express high affinity IL-2 receptor. These results indicate that 
CD25 expressing B cells may have a significant effect on themselves in 
an autocrine manner initiating proliferation. 
CD25+ B cells display high expression of the costimulatory molecules 
CD80 and CD86, and MHC-II on their surface ([124] paper I). This gives 
an indication that CD25+ B cell are activated and more efficient to 
present antigens. Indeed when MLR was performed using allogenic T 
cells, CD25+ B cells originating form healthy individuals performed  
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better as alloantigen presenting cells compared to CD25- B cells. The 
use of anti-CD25 antibody, neutralising CD25 expression on B cells, 
prior to MLR almost totally abolished the T cell response indicated 
that CD25 is not just a part of IL-2 receptor but may also play an 
important role during antigen presentation [56]. If this is the case for 
CD25+ B cells of RA and SLE patients is presently unknown. 
Interestingly, the expression of CD80 was higher on CD25+ B cells 
from RA and SLE patients compared to CD25+ B cells of healthy 
controls suggesting similar properties ([124] paper I). Keeping in mind 
the better ability of CD25+ B cells as alloantigen presenting cells it is 
reasonable to think that these cells are involved in the pathogenesis of 
the autoimmune diseases.  
The intracellular expression of Foxp3 together with CD25 on T cells 
have during a long time been consider as a marker for regulatory T 
cells [127, 128], so the question if CD25 expression on B cells will be a 
marker of regulatory B cells is obvious. First, CD25+ B cells do not 
express Foxp3 [56]. Secondly, while T regulatory cells suppress other 
cells of the immune system, it has been shown that CD25+ B cells 
activate the immune system. This contradictory findings makes it 
difficult to use the terminology regulatory regarding CD25+ B cells 
[56]. 
It has been shown that CD5+ B cells of RA patient produce autoreactive 
antibodies after stimulation in vitro [129]. However, we did not find 
any difference regarding CD5 expression between CD25+ and CD25- B 
cells in RA and SLE patients ([124] paper I). In mice CD5+ B cells belong 
to the B1 subpopulation and as mentioned before, this population of B 
cells form short lives plasma cells which after activation secrete low 
affinity antibodies [27]. However, the existence of B-1 cells in humans 
remains to be elucidated. 
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MOUSE CD25+ B CELLS 
 
Phenotype of murine CD25+ B cells 
During the murine B cell development CD25 is expressed on pre-B cells 
[17]. However, no one has so far investigated the phenotype or 
function of mature CD25 expressing B cells in healthy mice. Therefore, 
we phenotypically analysed CD25 expressing B cells from primary 
(bone marrow) and secondary (spleen, lymph nodes, Peyer´s patches 
and peritoneal cavity) lymphoid organs and blood from healthy mice. 
The frequency of CD25+ B cells varied considerably between primary 
and different secondary lymphoid organs. In bone marrow, 49% of B 
cells expressed CD25, 15,8% of B cells in peritoneal cavity, 2% of spleen 
B cells and 0,9% of lymph nodes B cells. There were no CD25 
expressing B cells present in blood or Peyer´s patches, figure 7, ([18] 
paper III). In agreement with published data, CD25 expressing B cells 
in bone marrow were of naive phenotype expressing high levels of 
AA4.1 when compared to CD25- B cells. B cells expressing CD25 in  
spleen, lymph nodes and peritoneal cavity cells on the other hand, 
display a more mature and activated phenotype.  
 
 
 
 
 
 
 
 
 
 
Figure 7: Frequency of CD25 expression on B cells from primary and 
secondary lymphoid organs from mice.  
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These CD25+ B cells expressed high levels of the costimulatory 
molecules CD80 and CD86, membrane bound IgA and IgG and CD69 
([18] paper III). MHC-II was highly expressed on both CD25+ and CD25- 
B cells. The quadruple staining for high affinity IL-2 receptor subunits 
(CD25, CD122 and CD132 in combination with CD19) showed that in 
spleen, lymph nodes and peritoneal cavity cells around 10% of the B 
cells stained positive for entire receptor ([18] paper III). 
 
Function of murine CD25+ B cells 
B cells have the ability to produce cytokines of various types. 
Therefore we analysed the cytokine production pattern in response to 
different stimuli of murine CD25+ B cells isolated from the spleen of 
healthy mice. CD25 expressing B cells produced higher levels of IL-6, 
IFN-γ and IL-10 in response to the TLR9 ligand CpG-ODN, TLR 4 ligand 
LPS and TLR2 ligand Pam
3
Cys as compared to CD25- B cells. IL-4 
production of CD25+ B cells was higher after stimulation with CpG-
ODN only. In contrast, we did not detect any production of IL-2 or TNF 
by these cells ([52] paper IV). This suggests that murine CD25 
expressing B cells may be an important source of cytokines during 
inflammation. However, whether this finding is consistent in 
autoimmune models remains to be elucidated. 
It is known that B cells are APC and contribute to the differentiation of 
T cells [2, 130]. We have shown that murine CD25 expressing B cells 
are significantly better at presenting alloantigen to CD4+ T cells when 
compared to CD25 negative B cells in the MLR assay ([52] paper IV). 
CD25+ B cells also express higher levels of the costimulatory molecules 
CD80 and CD86 together with MHC-II when compared to CD25 
negative B cells and produce different cytokines ([18, 52] papers III and 
IV). Having all the signals needed to activate a T cell, the impact of 
CD25 expressing B cells is of interest in forming memory formation  
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to a specific antigen as well as its potential role in autoimmune 
diseases. In mice, CD25+ B cells secrete increased levels of 
immunoglobulins of classes IgA, IgG and IgM when compared to CD25- 
B cells ([52] paper IV). In fact, we have shown that murine CD25+ B 
cells coexpress CD5, which suggest that these cells may in fact belong 
to the B-1a subpopulation of B cells secreting natural antibodies. This 
is in contrast to the results form the human studies showing that 
CD25+ B cells do not secrete high levels of immunoglobulins [56]. It 
can be due to differences between the species, or an indication that 
CD25 expression on human and mice B cells have different functions.  
Since the phenotypical classification states CD25+ B cells as more 
mature due to the surface immunoglobulin expression and the 
functional characterisation shows higher immunoglobulin secretion we 
suggest that murine CD25+ B cells may in fact belong to the memory B 
cell population. Therefore, it is tempting to suggest that CD25 can be 
used as a memory marker for B cells from secondary lymphoid organs 
in mice.  
To further investigate this question we immunised mice with the 
protein antigen ovalbumin (OVA) and analysed CD25+ versus CD25- B 
cells with respect to the ability to secrete OVA specific antibodies. We 
found that CD25 expressing B cells produce higher levels of OVA 
specific antibodies of class IgG and IgM when compared to CD25 
negative B cells ([52] paper IV). A B cell that produces antigen specific 
antibodies has gone through a phase of development including 
immunoglobulin class switch and somatic hypermutation, and in 
support to our theory, belongs to memory B cell population.   
We have also shown that there is no difference in how the subsets 
CD25+ and CD25- B cells respond to different stimuli targeting TLR2 
(Pam
3
Cys), TLR4 (LPS) and TLR9 (CpG-ODN) ([52] paper IV). Even if  
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CD25 expressing B cells are more mature the expansion of the CD25 
negative B cells seem to be of equal important when a foreign antigen 
has entered the body and the immune system has to take care of it. 
This is just an indication that when it is needed, all B cell subsets will 
respond although in different ways. 
CD69 has long been used as a marker for activated cells. Mitogen 
stimulation of mature B cells in vitro leads to CD25 expression and it 
has been accepted that CD25 is a marker of activated B cells. The 
question we asked was if this is also true in vivo. To answer this we 
infected mice with S. aureus collected spleen cells at different time 
points after inoculation and stained for CD25 and CD69 expression. 
Interestingly, we did not see any upregulation of CD25 on B cells in 
vivo. In contrast to the CD25 expression, the expression of CD69 on B 
cells raised strongly after infection in vivo ([52] paper IV). These 
findings together with our other data regarding CD25+ B cells in mice 
make us believe that CD25 is not just a marker for activated B cells 
but represents an unique subpopulation with very distinct 
phenotypical and functional properties and belongs perhaps within the 
memory B cell population.  
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CONCLUDING REMARKS 
 
B cells play an important role in the immune system and in the 
immunological memory by producing antibodies that makes up a 
crucial defence against foreign antigens attacking the body. However, 
if B cells recognize and produce antibodies to self-antigens the attack 
will be shifted towards the body itself and an autoimmune disease 
might evolve. There are many different subpopulations of B cells 
simultaneously present in the body. Each one of these subsets has its 
own function.  
Depletion of B cells has so far been proven to be efficient treatments 
in B cell lymphomas and also in certain autoimmune diseases such as 
RA and SLE. The depletion of B cells is a relatively new treatment. Even 
if the risk of infection has thus far not been increased, the imbalance 
of the immune system introduced by lack of mature B cells in 
circulation can not be ignored. It may be the time to start looking for 
more precise treatment, for example depleting only certain B cell 
subpopulations.  
 
In this thesis, a new subset of B cells identified by its surface 
expression of CD25 has been studied phenotypically in healthy 
individuals and in patients with the autoimmune diseases RA and SLE. 
This population of B cells show a mature and activated phenotype and 
is also a part of the memory B cells population. Memory B cells are 
antigen specific, long lived and may play a role in an autoimmune 
disease. Further work is needed to investigate if CD25 expressing B 
cells are specific for autoantigens in patients with RA or SLE.  
Another finding that should not be ignored is the ability of CD25+ B 
cells to produce IL-10. It has recently been shown that IL-10 producing 
B cells in mouse models of RA and SLE play an anti-inflammatory role. 
The presence of IL-10 producing human B cells in autoimmunity has  
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also been proved, but if they play a beneficial or pathogenic role is 
presently unknown. The mouse studies performed showed that also in 
mice CD25+ B cells display an activated and mature phenotype and are 
able to become antigen specific antibody secreting cells upon active 
immunisation. In addition, CD25+ B cells also produce IL-10 after 
stimulation in vitro. Characterisation of CD25 expressing B cells in 
mice can be a first step in development of a mouse model to further 
investigate the role of these B cells in the immune system.  
Overall we suggest that CD25 expressing B cells both in human and 
mice are part of a unique population of memory B cells. However, 
further studies are needed to understand the function of these cells 
and their role in the normal immune system and in the disease.   
 
 
 
Figure 8: CD25 expressing B cells may be involved in the defence against 
foreign antigens but if autoreactive may play an important part in 
autoimmunity and its pathogenesis. 
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There are two important differences we have found so far during our 
studies of CD25 expressing B cells in human and mice. The CD25+ B 
cells are present in the blood of humans but are not in mice. The 
second difference is regarding immunoglobulin secretion. Human 
CD25+ B cells secrete low levels of immunoglobulins in contrast to 
their murine counterparts that secrete high levels. We can almost 
certainly say that human CD25 expressing B cells belong to the 
memory B cell population and their presence in circulation and low 
secretion of immunoglobulins support our hypothesis. Murine CD25+ B 
cells also resemble memory B cells, even though they secrete 
immunoglobulins. However, further studies are needed to confirm 
these findings. The ability of murine CD25+ B cells to produce high 
levels of immunoglobulins may suggest that these cells are activated 
or on their way to become plasma cells. One explanation can be the 
biological difference between the species. At the moment we do not 
have any explanation for this differences but we hope that further 
studies will give the answers.  
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MAIN CONCLUSIONS FROM THE THESIS 
 
Paper I 
During normal conditions the development, differentiation and 
selection process of B cells is relatively well controlled. However, 
autoreactive B cells occur in the process of autoimmune diseases such 
as rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) 
giving rise to pathology. Therefore it is important to understand the 
different role of B cell subpopulations. In this study we phenotypically 
characterised B cells from healthy controls and patients with RA and 
SLE regarding their expression of surface CD25. Our results indicate 
that CD25+ B cells originating from RA and SLE patients and from 
healthy controls are in a highly activated state.  
 
Paper II 
Following our first study we asked to which B cells subset CD25 
expressing B cells belong. Our results show that CD25+ B cells from 
healthy controls, RA and SLE patients, constitute a unique 
subpopulation preferentially occurring within the CD20+CD27+ 
memory B cells. These cells may play role in the defence against 
microbial agents in the normal immune system but also may be 
involved in the pathogenesis of different autoimmune diseases by 
being a part of the immunological memory recognizing autoantigens.  
 
Paper III 
Mouse B cells are relatively well characterised. They are in analogy 
with T cells capable of expressing the functional IL-2 receptor. CD25 
(IL-2R α-chain) positive T cells have been studied in detail but 
knowledge about murine CD25 expressing B cells is scarce. Our results 
indicate that B cells expressing CD25 are phenotypically distinctly 
different from those that are CD25 negative. Our findings suggest that  
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CD25+ B cells are more prone to present antigen and display a more 
mature phenotype.   
 
Paper IV 
B cells are an important part of both the innate and adaptive immune 
system. Their ability to produce antibodies, cytokines, and to present 
antigens makes them a crucial part in defence against pathogens. In 
this study we have functionally characterised CD25 expressing murine 
B cells. We found that CD25+ B cells secrete high levels of IL-4, IL-6, IL-
10, INF-γ and are better at presenting alloantigen to CD4+ T cells. They 
also spontaneously produce higher levels of IgA, IgG and IgM when 
compared to CD25- B cells. In addition, CD25+ B cells are significantly 
better at secreting antigen-specific antibodies of the IgM and IgG class 
after immunisation. Our results demonstrate that CD25+ B cells are 
highly activated and functionally mature. Therefore, we suggest that 
this population plays a major role in the immune system belonging to 
the memory B cell population and that CD25 may be used a memory 
marker. 
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POPULÄRVETENSKAPLIG SAMMANFATTNING 
 
För att kunna försvara sig mot de stora mänger bakterier och virus 
som vi människor dagligen kommer i kontakt med har ett väl 
fungerande immunförsvar utvecklats. Immunförsvaret består av ett 
stort antal olika vita blodkroppar och deras produkter. Den viktigaste 
uppgiften för immunförsvaret är att försvara kroppen mot främmande 
farliga ämnen samtidig som den måste känna igen och ignorera ämnen 
som inte är farliga eller som är kroppsegna.  
Vita blodkoppar utbildas tidigt att inte reagera på kroppsegna ämnen 
och de ofarliga främmande ämnen som finns runt omkring oss, till 
exempel ämnen i vår mat. Tyvärr fungerar inte alltid kontrollen av 
cellerna och ibland blir det fel. Reagerar immunförsvaret på ett 
fullständig ofarlig ämne som björkpollen kommer det leda till en 
allergisk reaktion medan om den angriper organen i den egna kroppen 
leder det till utveckling av en autoimmun sjukdom som reumatism.  
 
Immunförsvaret är uppdelat i två delar, det medfödda, ospecifika 
immunförsvaret och det förvärvade immunförsvaret, vilken är 
specifikt och är en del av det immunologiska minnet. En typ av vita 
blodkroppar som är delaktig både i det medfödda och förvärvade 
immunförsvaret kallas B-celler. B-cellers främsta uppgift är att 
producera antikroppar (immunoglobuliner). I det medfödda 
immunförsvaret producerar B-celler naturliga antikroppar som 
reagerar på olika delar av bakterier eller virus. I det förvärvade 
immunförsvaret är antikropparna specifika och känner igen bara en 
enda struktur. B-celler kan också utsöndra signalämnen, så kallade 
cytokiner och kemokiner, som talar om för andra celler i 
immunförsvaret vad som pågår och hur de skall bete sig och vart de 
skall ta vägen. Den tredje uppgiften B-celler har är att ta in olika 
ämnen och vissa upp de för T-celler, som är en annan viktig cell i det  
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förvärvade immunförsvaret, och aktivera dessa så att immunsvaret 
mot ett ämne blir starkare och mer effektivt.  
 
Det är naturligtvist mycket viktig att kroppen försvaras men ännu 
viktigare är att kroppens egna organ inte angrips och förstörs. För att 
förhindra detta har immunförsvaret ett antal skyddsmekanismer. Efter 
att B-celler bildas i benmärgen går de genom en kontroll där de celler 
som känner igen kroppsegna ämnen och bildar antikroppar mot dem 
tas bort. Tyvärr fungerar inte alltid de kontrollmekanismer kroppen 
har. Det leder till att B-celler, som reagerar på kroppsegna ämnen på 
samma sätt som främmande, släpps ut från benmärgen och börjar 
bilda antikroppar som i sin tur angriper kroppens olika organ vilket 
kan leda fram till utveckling av en så kallad autoimmun sjukdom. Att 
B-celler är en viktig del av autoimmuna sjukdomar som reumatism har 
visats med hjälp av en specifik behandling där B celler slås ut hos 
patienter med dessa sjukdomar. De patienter som svarar bra på 
behandlingen blir symptomfria och mår bättre i upp till nio månader 
eller mer efter behandlingen. Symptomen för sjukdomen kommer 
tillbaka när B-celler hittas i blodet igen. 
 
Vi är intresserade av en särskild B-cell som kan identifieras med hjälp 
av en markör (protein) på dess yta. Den markör vi har använt oss av 
kallas för CD25. Vi undersökte B-cellers utseende och egenskaper med 
hjälp av CD25 och andra markörer inte bara hos friska vuxna utan 
också hos patienter som hade fått diagnosen reumatism (RA) eller 
systemic lupus erythematosus (SLE). Vi fann att B-celler som utryckte 
CD25 var mogna och aktiverade. Vidare kunde vi också vissa att dessa 
B-celler är så kallade minnes B-celler. Det immunologiska minnet är 
viktigt för att kunna känna igen, snabbt reagera och bekämpa ett 
främmande ämnen som redan har blivit bekämpat av immunförsvaret 
tidigare och som på nytt skulle kunna utgöra en fara. Minnesceller är 
viktig del av immunförsvaret hos friska, samtidigt kan dessa celler  
                                                                                                 
                                                                  The expression and function of CD25 B cells in man and in mice                                                                                                        
-------------------------------------------------------------------------------------------------------    
 47 
 
vara riktigt farliga för de som lider av olika autoimmuna sjukdomar, 
då minnescellerna istället känner igen kroppsegna ämne och reagerar 
på dem. Detta innebär att de kommer att vara aktiva och bilda 
antikroppar och cytokiner och på så sätt ökar angreppen mot kroppen. 
Vi tror att de B-celler som vi har undersökt kan vara involverade i 
sjukdoms mekanismerna hos RA and SLE patienter. Fler studier 
behövs för att säkert kunna säga vad dessa B-celler har för funktion i 
immunförsvaret hos friska personer och hos dem som lider av 
autoimmuna sjukdomar. 
 
Möss har länge används som modell för olika mänskliga sjukdomar. 
De har studerats för att bättre förstå en sjukdoms utveckling samt de 
olika vita blodkropparnas funktion under sjukdomen. Vi har använt 
oss av samma ytmarkör, CD25, som vi har använt i våra studier av 
mänskliga B-celler för att kunna identifiera dessa specifika B-celler hos 
möss. Målet har varit att undersöka B-celler som bär på CD25 i möss 
och förhoppningsvis kunna utveckla en modell för autoimmuna 
sjukdomar och vidare studera deras funktion. Vi fann att CD25 
uttryckande B celler hos möss liksom hos människor är mer mogna 
och aktiverade än de som saknar CD25 på sin yta. De är också bättre 
på att bilda antikroppar och signalämnen, cytokiner. Vidare kunde vi 
se att dessa B-celler kunde aktivera T-celler och få dem att föröka sig. 
Dessa resultat indikerar att de B-cells vi har studerat har en klar 
funktion i immunförsvaret. Dessa B-celler verkar ha det som behövs 
för att kunna vara med i vanliga immunologiska reaktioner men också 
i olika autoimmuna sjukdomar.  
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